3D Medicines, Inc. is an investment holding company, which engages in biopharmaceutical research and development. It focuses on the development of differentiated immuno-oncology drugs. The company was founded by Zhao Long Gong in 2014 and is headquartered in Shandong, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company